We have previously demonstrated that supplementation of endogenous Tregs utilizing a highly purified, exogenously activated and expanded Treg subset characterized by CD4+CD25+CD62LHI expression can inhibit the onset and rate of progression of lupus in (NZBxNZW)F1 (B/W) mice[24]. Here, CD4 is linked to systemic lupus erythematosus.